This study found that ACSM6 may act as a potential molecular biomarker for assessing the tumor microenvironment status in various types of cancer, particularly in BLCA and thymoma, and may lead to the formation of a non-inflammatory TME in BLCA. Here, ACSM6 is linked to bladder transitional cell carcinoma.